Meeder Asset Management’s Immune Design Corp. IMDZ Stock Holding History

Meeder Asset Management’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-581	Closed	-$3K	–	2251
2019 Q1	$3K	Sell	581 -1,237	-68%	-$4.21K	﹤0.01%	1535
2018 Q4	$2K	Buy	+1,818	New	+$3.16K	﹤0.01%	1613
2018 Q2	–	Sell	-387	Closed	-$1K	–	1780
2018 Q1	$1K	Buy	387 +154	+66%	+$545	﹤0.01%	1539
2017 Q4	$1K	Buy	233 +74	+47%	+$403	﹤0.01%	1638
2017 Q3	$2K	Sell	159 -181	-53%	-$1.78K	﹤0.01%	1526
2017 Q2	$3K	Hold	340	–	–	﹤0.01%	1378
2017 Q1	$2K	Sell	340 -1,356	-80%	-$7.84K	﹤0.01%	1475
2016 Q4	$9K	Buy	+1,696	New	+$12K	﹤0.01%	786

Meeder Asset Management's IMDZ Position: Q2 2019 in Review

Meeder Asset Management sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 581 shares — an estimated $3K sold.

Meeder Asset Management first reported a position in IMDZ in Q4 2016 and held it in 8 quarters. The position peaked at $9K in Q4 2016. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.

Meeder Asset Management reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
Meeder Asset Management sold 581 Immune Design Corp. shares in Q2 2019, an estimated $3K.
Meeder Asset Management first reported a position in Immune Design Corp. in Q4 2016 and held it in 8 quarters.
Meeder Asset Management's Immune Design Corp. position peaked at $9K in Q4 2016.
0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.

Based on Meeder Asset Management's 13F filing for Q2 2019, filed 5 Aug 2019.